259 related articles for article (PubMed ID: 20586561)
1. Fighting antibiotic resistance all over Europe.
Tacconelli E; De Angelis G
Expert Rev Anti Infect Ther; 2010 Jul; 8(7):761-3. PubMed ID: 20586561
[TBL] [Abstract][Full Text] [Related]
2. ESCAIDE 2015: an operational scientific conference on infectious diseases for professionals from Europe and beyond.
Sabbatucci M; Jasir A
Euro Surveill; 2016; 21(11):30166. PubMed ID: 27020459
[No Abstract] [Full Text] [Related]
3. The role of the laboratory in choosing antibiotics.
Coghe F; Orrù G; Pautasso M; Ferraguti P; Sanna P; Fanos V
J Matern Fetal Neonatal Med; 2011 Oct; 24 Suppl 2():18-20. PubMed ID: 21740333
[TBL] [Abstract][Full Text] [Related]
4. A report from the 20th European Congress of Clinical Microbiology and Infectious Diseases (April 10-13, 2010 - Vienna, Austria).
Rabasseda X
Drugs Today (Barc); 2010 Jul; 46(7):533-42. PubMed ID: 20683506
[TBL] [Abstract][Full Text] [Related]
5. 27th Annual Meeting of the European Society for Paediatric Infectious Diseases.
Ulloa-Gutierrez R; Hernández-de Mezerville M
Expert Rev Anti Infect Ther; 2009 Oct; 7(8):937-9. PubMed ID: 19803701
[TBL] [Abstract][Full Text] [Related]
6. Harmonization of antimicrobial susceptibility testing breakpoints in Europe: implications for reporting intermediate susceptibility.
Brown D; Macgowan A
J Antimicrob Chemother; 2010 Feb; 65(2):183-5. PubMed ID: 19996143
[TBL] [Abstract][Full Text] [Related]
7. European standards for antibiotic susceptibility testing: towards a theoretical consensus.
Baquero F
Eur J Clin Microbiol Infect Dis; 1990 Jul; 9(7):492-5. PubMed ID: 2226478
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic microbiology and therapeutic drug monitoring in pediatric infectious diseases.
Jacobs MR; Myers C
Pediatr Clin North Am; 1983 Feb; 30(1):135-59. PubMed ID: 6338461
[No Abstract] [Full Text] [Related]
9. Selective reporting of antibiotic susceptibility test results in European countries: an ESCMID cross-sectional survey.
Pulcini C; Tebano G; Mutters NT; Tacconelli E; Cambau E; Kahlmeter G; Jarlier V;
Int J Antimicrob Agents; 2017 Feb; 49(2):162-166. PubMed ID: 28093208
[TBL] [Abstract][Full Text] [Related]
10. [Antibacterial spectrum of an antibiotic and clinical categorization].
Cavallo JD; Mérens A
Pathol Biol (Paris); 2008 Jul; 56(5):300-4. PubMed ID: 18178037
[TBL] [Abstract][Full Text] [Related]
11. Antimicrobial stewardship programs: methods of operation and suggested outcomes.
Griffith M; Postelnick M; Scheetz M
Expert Rev Anti Infect Ther; 2012 Jan; 10(1):63-73. PubMed ID: 22149615
[TBL] [Abstract][Full Text] [Related]
12. Infectious disease 2001: drug resistance, new drugs.
Georgopapadakou NH
Drug Resist Updat; 2002 Oct; 5(5):181-91. PubMed ID: 12450783
[TBL] [Abstract][Full Text] [Related]
13. Highlights from the 13th European Congress of Clinical Microbiology and Infectious Diseases in Glasgow, Scotland, May 10-13, 2003. The complex world of infectious diseases.
Jack D
Drug News Perspect; 2003; 16(6):399-401. PubMed ID: 12973451
[TBL] [Abstract][Full Text] [Related]
14. [Antibiotic strategy in an infectious diseases unit].
Dupon M
Presse Med; 2000 Jan; 29(2):121-3. PubMed ID: 10682044
[No Abstract] [Full Text] [Related]
15. Abstracts of the 20th ECCMID (European Congress of Clinical Microbiology and Infectious Diseases). Vienna, Austria. April 10-13, 2010.
Clin Microbiol Infect; 2010 Apr; 16 Suppl 2(Suppl 2):S1-720. PubMed ID: 20412063
[No Abstract] [Full Text] [Related]
16. Building an Antimicrobial Stewardship Program: Cooperative Roles for Pharmacists, Infectious Diseases Specialists, and Clinical Microbiologists.
Kim J; Craft DW; Katzman M
Lab Med; 2015; 46(3):e65-71. PubMed ID: 26283698
[TBL] [Abstract][Full Text] [Related]
17. Improving outcomes in the management of Gram-negative bacterial infections in the face of growing antimicrobial resistance.
Mayor S
Future Microbiol; 2016 Oct; 11():1223-1226. PubMed ID: 27680185
[TBL] [Abstract][Full Text] [Related]
18. Comparison of antimicrobial susceptibility test breakpoints of national societies.
Degener JE; Phillips I
Clin Microbiol Infect; 2001 Feb; 7(2):51-4. PubMed ID: 11298142
[No Abstract] [Full Text] [Related]
19. Nationwide surveillance of bacterial respiratory pathogens conducted by the surveillance committee of Japanese Society of Chemotherapy, the Japanese Association for Infectious Diseases, and the Japanese Society for Clinical Microbiology in 2010: General view of the pathogens' antibacterial susceptibility.
Yanagihara K; Kadota J; Aoki N; Matsumoto T; Yoshida M; Yagisawa M; Oguri T; Sato J; Ogasawara K; Wakamura T; Sunakawa K; Watanabe A; Iwata S; Kaku M; Hanaki H; Ohsaki Y; Watari T; Toyoshima E; Takeuchi K; Shiokoshi M; Takeda H; Miki M; Kumagai T; Nakanowatari S; Takahashi H; Utagawa M; Nishiya H; Kawakami S; Kobayashi N; Takasaki J; Mezaki K; Konosaki H; Aoki Y; Yamamoto Y; Shoji M; Goto H; Saraya T; Kurai D; Okazaki M; Niki Y; Yoshida K; Kawana A; Saionji K; Fujikura Y; Miyazawa N; Kudo M; Sato Y; Yamamoto M; Yoshida T; Nakamura M; Tsukada H; Imai Y; Tsukada A; Kawasaki S; Honma Y; Yamamoto T; Ban N; Mikamo H; Sawamura H; Miyara T; Toda H; Sato K; Nakamura T; Fujikawa Y; Mitsuno N; Mikasa K; Kasahara K; Sano R; Sugimoto K; Asari S; Nishi I; Toyokawa M; Miyashita N; Koguchi Y; Kusano N; Mihara E; Kuwabara M; Watanabe Y; Kawasaki Y; Takeda K; Tokuyasu H; Masui K; Negayama K; Hiramatsu K; Aoki Y; Fukuoka M; Magarifuchi H; Nagasawa Z; Suga M; Muranaka H; Morinaga Y; Honda J; Fujita M
J Infect Chemother; 2015 Jun; 21(6):410-20. PubMed ID: 25817352
[TBL] [Abstract][Full Text] [Related]
20. Development of the EUCAST disk diffusion antimicrobial susceptibility testing method and its implementation in routine microbiology laboratories.
Matuschek E; Brown DF; Kahlmeter G
Clin Microbiol Infect; 2014 Apr; 20(4):O255-66. PubMed ID: 24131428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
